GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue
· bloomberg.com · popularity 56/100 · 0 similar stories today · Pharmaceuticals & Medical Research (Health & Life Sciences)
Read the original at bloomberg.com →
Summary
Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.
Found in: Investing, Bloomberg, Bloomberg Markets. Rating basis: single outlet; outlet tier 5; 3 feeds; listed 3 times; feed position 5.